Mario Poljak
Impact in
- Epidemiology top 0.2%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
Papers in
- Virology 39
- HIV Research and Treatment 27
- Epidemiology 252
- Cervical Cancer and HPV Research 174
- Hepatitis B Virus Studies 83
- Liver Disease Diagnosis and Treatment 21
- Co-authors
- Katja SemeBoštjan J. KocjanNina GalePolona J. MaverMarc ArbynChris J.L.M. MeijerNina ZidarAnja Šterbenc
In The Last Decade
Mario Poljak
357 papers receiving 8.6k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Epidemiology 5.8k
- Otorhinolaryngology 701
- Microbiology 853
- Virology 477
- Infectious Diseases 1.3k
Countries citing papers authored by Mario Poljak
This map shows the geographic impact of Mario Poljak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Poljak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Poljak more than expected).
Fields of papers citing papers by Mario Poljak
This network shows the impact of papers produced by Mario Poljak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Poljak. The network helps show where Mario Poljak may publish in the future.
Co-authors
The 25 scholars most cited alongside Mario Poljak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 5 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 27 | |
| 8 | 2020 | 22 | |
| 9 | 2019 | 16 | |
| 10 | 2019 | 2 | |
| 11 | 2018 | 28 | |
| 12 | 2018 | 84 | |
| 13 | 2018 | 25 | |
| 14 | 2018 | 10 | |
| 15 | 2015 | 131 | |
| 16 | Current status of human papillomavirus vaccination implementation in central and eastern Europe. | 2013 | 17 |
| 17 | [Recent developments in serologic and molecular diagnosis of hepatitis B and C]. | 2013 | 3 |
| 18 | European recommendations for the clinical use of HIV drug resistance testing: 2011 update. | 2011 | 104 |
| 19 | Slovene national guidelines for the prevention of hepatitis B reactivation in patients undergoing immunosuppressive therapy | 2010 | 1 |
| 20 | 1997 | 1 |
About Mario Poljak
Mario Poljak is a scholar working on Virology, Epidemiology, Otorhinolaryngology, Hepatology and Microbiology, having authored 370 papers that have together received 8.8k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (174 papers), Hepatitis B Virus Studies (83 papers), Molecular Biology Techniques and Applications (63 papers), Genital Health and Disease (61 papers), Hepatitis C virus research (47 papers), Head and Neck Cancer Studies (29 papers), HIV Research and Treatment (27 papers) and Liver Disease Diagnosis and Treatment (21 papers). The work is most often cited by research in Epidemiology (5.8k citations), Otorhinolaryngology (701 citations), Microbiology (853 citations), Virology (477 citations) and Infectious Diseases (1.3k citations). Mario Poljak has collaborated with scholars based in Slovenia, Belgium and Croatia. Frequent co-authors include Katja Seme, Boštjan J. Kocjan, Nina Gale, Polona J. Maver, Marc Arbyn, Chris J.L.M. Meijer, Nina Zidar, Marc Arbyn, Anja Šterbenc and Anja Oštrbenk. Their work appears in journals such as Journal of Clinical Virology, Clinical Microbiology and Infection, Journal of Clinical Microbiology, Journal of Medical Virology and Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.